Daniel Hochhauser
Daniel Hochhauser is a renowned oncologist and medical researcher specializing in the field of cancer treatment and research. He is currently a Kathleen Ferrier Professor of Medical Oncology at the University College London Cancer Institute.
Early Life and Education[edit | edit source]
Daniel Hochhauser was born and raised in London, United Kingdom. He completed his undergraduate studies in medicine at the University of Cambridge, where he developed a keen interest in oncology. He later pursued his postgraduate studies at the University of Oxford, focusing on cancer research.
Career[edit | edit source]
Hochhauser started his career as a medical researcher, focusing on the development of new chemotherapy drugs and treatments for cancer. He has made significant contributions to the field of oncology, particularly in the development of personalized cancer treatments. He is currently the Kathleen Ferrier Professor of Medical Oncology at the University College London Cancer Institute, where he continues his research and also teaches medical students.
Research[edit | edit source]
Hochhauser's research primarily focuses on the development of new drugs for the treatment of cancer. He has been involved in numerous clinical trials and has published extensively in peer-reviewed medical journals. His work has significantly contributed to the understanding of cancer biology and the development of new treatment strategies.
Awards and Recognition[edit | edit source]
Throughout his career, Hochhauser has received numerous awards and recognition for his contributions to the field of oncology. He is a member of several prestigious medical societies and has been invited to speak at numerous international conferences.
Personal Life[edit | edit source]
Hochhauser is married and has two children. He enjoys running and is an avid reader of literature.
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD